Category: us corporate news

us corporate news

Chicago Rivet & Machine Co. 2025 Annual Report: Financial Results, Risk Factors, and 2026 Outlook

Minichart

March 25, 2026

Chicago Rivet & Machine Co. 2025 Annual Report: Key Investor...

Continue Reading 0

us corporate news

Sanara MedTech Inc. 2025 Business Overview: Surgical Product Focus, Innovation Strategy, and Regulatory Compliance

Minichart

March 25, 2026

Sanara MedTech Inc. 2025 Annual Report: Key Highlights for I...

Continue Reading 0

us corporate news

GameStop Corp. 2025 Business Strategy: Retail Optimization, Capital Allocation, and Investment Risks

Minichart

March 25, 2026

GameStop 2025-2026 Annual Report: Key Investor Highlights ...

Continue Reading 0

us corporate news

Neurogene Inc. Advances Gene Therapy for Rare Neurological Diseases with EXACT Platform and NGN-401 Clinical Development

Minichart

March 25, 2026

Neurogene Inc. 2025 Annual Report: Key Highlights and Invest...

Continue Reading 0

us corporate news

BioCardia, Inc.: Advancing Cell Therapy Systems for Heart Failure and Cardiovascular Disease – Clinical Trials, FDA Approvals, and Business Strategies (2025)

Minichart

March 25, 2026

BioCardia 2025 Annual Report: Key Insights for Investors ...

Continue Reading 0

us corporate news

Disease-Modifying Therapies for Obesity and Type 2 Diabetes: Revita and Rejuva Pipeline Overview

Minichart

March 25, 2026

Fractyl Health, Inc. 2025 Annual Report: Key Highlights for ...

Continue Reading 0

us corporate news

Comstock Inc. 2025 Annual 10-K Report: Business Segments, Investments, and Lease Agreements Overview

Minichart

March 25, 2026

Comstock Inc. 2025 Annual Report: Key Insights for Investors...

Continue Reading 0

us corporate news

VirnetX Holding Corporation 2025 Annual Report: Cybersecurity Solutions, Financials, Risks, and Business Overview

Minichart

March 25, 2026

VirnetX Holding Corp. 2025 Annual Report: Key Insights for I...

Continue Reading 0

us corporate news

VIZZ by LENZ Therapeutics: FDA-Approved Once-Daily Eye Drop for Presbyopia Treatment and Market Opportunity 32

Minichart

March 25, 2026

LENZ Therapeutics, Inc. 2025 Annual Report: Key Highlights f...

Continue Reading 0

us corporate news

ECA Marcellus Trust I 2025 10-K Report: Financials, Risks, and Regulatory Overview for Natural Gas Royalty Interests

Minichart

March 25, 2026

Investor Article: ECA Marcellus Trust I 2025 Annual Report A...

Continue Reading 0